Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
34.15
+0.02 (0.06%)
At close: May 22, 2026, 4:00 PM EDT
34.15
0.00 (-0.01%)
After-hours: May 22, 2026, 7:57 PM EDT
Immunovant Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$44
Upside
+28.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $23 → $30 | Hold | Maintains | $23 → $30 | -12.15% | May 22, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $32 → $43 | Strong Buy | Maintains | $32 → $43 | +25.92% | May 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $40 | Strong Buy | Maintains | $35 → $40 | +17.13% | May 21, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $32 | Hold | Maintains | $29 → $32 | -6.30% | Apr 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +2.49% | Feb 10, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $41 → $44 | Strong Buy | Maintains | $41 → $44 | +28.84% | Feb 9, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $16 → $22 | Hold | Maintains | $16 → $22 | -35.58% | Jan 8, 2026 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $50 | Hold → Buy | Upgrades | $50 | +46.41% | Jan 6, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $18 → $28 | Hold | Maintains | $18 → $28 | -18.01% | Dec 15, 2025 |
| Truist Securities | Truist Securities | Hold Initiates $16 | Hold | Initiates | $16 | -53.15% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $37 → $33 | Buy | Maintains | $37 → $33 | -3.37% | Sep 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +2.49% | Sep 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $37 | Buy | Maintains | $40 → $37 | +8.35% | Aug 12, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $33 → $30 | Strong Buy | Maintains | $33 → $30 | -12.15% | Aug 12, 2025 |
| UBS | UBS | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -47.29% | Jul 28, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $38 → $17 | Strong Buy → Hold | Downgrades | $38 → $17 | -50.22% | Apr 22, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.